Central Venous Catheter Market

The global Central Venous Catheter Market is valued at USD 3.05 Billion in 2024 and is projected to reach a value of USD 6.01 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 6.35% between 2025 and 2035.

A central venous catheter (CVC) is a large, intravascular tube inserted into major veins to support the care of critically ill patients and those undergoing major surgeries. It is widely used in intensive care settings and during surgical procedures. The multi-lumen structure of CVCs allows for monitoring central venous pressure (CVP), collecting blood samples, and administering multiple intravenous solutions or medications at the same time.

Key Highlights

• In 2024, based on the Product Type, the Non-Tunneled Catheters category accounted for significant market share of 45.5%
• Based on the Property, the Non-Antimicrobial Catheters category accounted for significant market share if 62.3% in 2024
• By Design, Double Lumen segment dominated the Central Venous Catheter market in 2024 with significant market share of 35.5%
• In 2024, by End-User, Hospitals dominated the market with market share of 60.5%
• North America dominated the Central Venous Catheter market with 44.3% market share in 2024
• Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period

Product Type Overview

​The Product Type segment is divided into Tunneled Catheters and Non-Tunneled Catheters. The Non-Tunneled Catheters segment held the largest share of 45.5% in the Central Venous Catheter market.

The non-tunneled catheter devices segment led the Central Venous Catheter Market and is expected to maintain its dominance throughout the forecast period. This growth is primarily driven by the rising prevalence of kidney disorders and an increase in accident-related cases. Additionally, the growing geriatric population is expected to further fuel the demand for central venous catheters, as older individuals are more vulnerable to chronic health conditions.

Property Overview

​The Property segment is divided into Antimicrobial Catheters and Non-Antimicrobial Catheters. The Non-Antimicrobial Catheters segment held the dominant share in 2024, accounting for significant market share of 62.3%.

The Non-Antimicrobial Catheter segment's market leadership is driven by the widespread use of traditional catheters, which continue to be favored in many clinical settings due to their lower cost compared to antimicrobial-coated alternatives. Non-antimicrobial catheters are widely used for short-term central venous access, particularly in patients with lower infection risks or in settings where infection prevention protocols are strictly followed. Despite the increasing demand for antimicrobial catheters, the non-antimicrobial segment remains the largest due to its affordability and established role in healthcare practices.

Design Overview

The Design segment is divided into Single Lumen, Double Lumen, Multiple Lumen. The Double Lumen segment held the largest share of 35.5% in the Central Venous Catheter market.

Double Lumen design is preferred for its versatility and ability to facilitate multiple medical treatments simultaneously, such as administering different medications or fluids, blood transfusions, or parenteral nutrition. The double lumen catheter’s ability to provide separate channels for different therapies makes it ideal for critically ill patients who require complex care and continuous monitoring. Its widespread use in various clinical settings, including intensive care units (ICUs) and oncology treatments, has contributed to its dominant position in the Central Venous Catheter market.

End-User Overview

The End User segment is bifurcated into Hospital, Cancer treatment centers, Others. Hospital dominated the market with market share of 60.5%.

Hospitals accounts for the largest market share for the Central Venous Catheter market due to it's critical role in providing intensive care and specialized treatments that often require central venous access. The high demand for central venous catheters in hospital settings is driven by the increasing number of surgeries, emergency procedures, and treatments for chronic diseases such as cancer, cardiovascular disorders, and kidney failure. Additionally, hospitals are equipped with advanced healthcare infrastructure, skilled medical professionals, and the necessary protocols for catheter insertion and management, making them the primary setting for the use of central venous catheters.

Regional Overview

In 2024, the North America captured 44.3% of the revenue share.

North America Central Venous Catheter market is driven by presence of advanced healthcare systems, robust adoption of cutting-edge medical devices, and an increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and kidney failure significantly contributes to the demand for central venous access devices. This region also has a substantial aging population, increasing the need for long-term medical interventions that often require the use of CVCs. The established healthcare infrastructure and the presence of advanced medical technology in North America further fuel market growth.

U.S. Central Venous Catheter Market

The U.S. {Keyword}} market, valued at USD 1.15 Billion in 2024 to USD 2.27 Billion in 2035, is anticipated to grow at a CAGR of 6.4% from 2025 to 2035. The U.S. dominated the North American Central Venous Catheter market with largest share in 2024, driven by the availability of well-established medical infrastructure, high levels of healthcare spending, and ongoing technological advancements in catheter design and safety features. Additionally, the expansion of home healthcare services and the rising number of outpatient procedures are contributing factors to the growing use of CVCs, as these devices provide a reliable solution for long-term drug administration and monitoring. Furthermore, regulatory approvals and guidelines from the U.S. Food and Drug Administration (FDA) play a crucial role in ensuring the safety and efficacy of CVCs, making the market more attractive for manufacturers. The growing focus on infection control and patient safety has led to the development of antimicrobial-coated and heparin-coated CVCs, further driving market growth.

Asia Pacific Central Venous Catheter Market

The Asia Pacific Central Venous Catheter market is set for significant growth with over the forecast period fueled by increasing investments in healthcare infrastructure across countries like China, India, and Southeast Asia. The region is experiencing rapid urbanization, leading to greater demand for advanced medical treatments and technologies. Rising incidences of diseases such as cancer, sepsis, and renal disorders, which necessitate the use of central venous catheters, further propel market growth. Additionally, government initiatives to improve healthcare access, coupled with growing awareness about the benefits of modern medical devices, are expected to play a pivotal role in the market’s expansion.

Europe Central Venous Catheter Market

Europe are expected to see growth during the forecast period driven by aging population, coupled with the increasing burden of chronic illnesses, is driving demand for reliable vascular access solutions. Moreover, the adoption of advanced medical devices, combined with efforts to streamline healthcare delivery, further supports market growth.Countries such as Germany, the UK, and France are leading contributors, benefiting from well-developed healthcare systems and high-quality medical services.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Key Trends

• Adoption of Coated Catheters: Increasing use of antimicrobial-coated and heparin-coated catheters to reduce infections and improve patient safety
• Technological Advancements: Development of ultrasound-guided catheter insertion techniques for enhanced accuracy and reduced complications
• Rising Prevalence of Chronic Diseases: High demand driven by conditions like cancer, cardiovascular disorders, and renal failure requiring long-term venous access
• Shift Toward Minimally Invasive Procedures: Growing preference for less invasive options in both hospital and outpatient settings
• Expansion of Home-Based Care: Increasing use of central venous catheters for home-based management of chronic illnesses
• Focus on Innovation: Continuous investments in R&D to develop advanced and specialized catheter solutions

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Market Drivers for Central Venous Catheter Market

The growing number of accidents and the rise in patients requiring critical care have significantly contributed to the expansion of the central venous catheter industry. Additionally, the increasing prevalence of kidney diseases and the rising number of dialysis patients are driving the growth of the Central Venous Catheter Market. For example, in 2020, over 562,000 Americans were undergoing dialysis, according to the American Kidney Fund. Since central venous catheters are commonly used in dialysis procedures, the growing demand for hemodialysis directly fuels the market’s growth.

Market Restraints for Central Venous Catheter market

The demand for central venous catheters is not only growing in developed nations but is also increasing in emerging markets like China, Brazil, and India. This demand is driven by factors such as rising hospital admissions, an increase in surgical procedures, and greater healthcare spending. Additionally, the rising frequency of accidents and emergency health conditions is expected to further propel market growth. However, issues like product recalls from manufacturers pose challenges to the overall growth of the market.

Market Opportunities for Central Venous Catheter market

The demand for central venous catheters is not only growing in developed nations but is also increasing in emerging markets like China, Brazil, and India. This demand is driven by factors such as rising hospital admissions, an increase in surgical procedures, and greater healthcare spending. Additionally, the rising frequency of accidents and emergency health conditions is expected to further propel market growth. However, issues like product recalls from manufacturers pose challenges to the overall growth of the market.

Competitive Landscape

The Central Venous Catheter market is characterized by the presence of several key players striving to enhance their market share through innovation, strategic collaborations, and acquisitions. Prominent companies such as Teleflex Incorporated, B. Braun Melsungen AG, and Medtronic are focused on developing advanced catheter technologies to improve patient outcomes and reduce complications. Emerging players are also gaining traction by introducing cost-effective and specialized solutions tailored to specific medical needs. Additionally, regulatory approvals, robust distribution networks, and investments in research and development play a crucial role in sustaining competitiveness in this dynamic market.

The key players in the global Central Venous Catheter market include - Medtronic plc, Becton, Dickinson and Company, Rex Medical, LLC., ICU Medical Inc., Vygon, Merit Medical Systems Inc., Teleflex Incorporated, AngioDynamics Inc., B. Braun SE among others.

Recent Market Developments

Merit Medical Acquires Surfacer Inside-Out Access Catheter System from Bluegrass Vascular Technologies

• In June 2023, Merit Medical Systems, Inc., a prominent global healthcare technology company, revealed its acquisition of the Surfacer Inside-Out access catheter system from Bluegrass Vascular Technologies, Inc.

ICU Medical Acquires Smiths Medical, Expanding Portfolio in Infusion and Vascular Access Solutions

• In January 2022, ICU Medical Inc. finalized the acquisition of Smiths Medical, a division of Smiths Group plc. The acquired portfolio encompasses syringe and ambulatory infusion systems, vascular access solutions, and critical care products

The global Central Venous Catheter market can be categorized as Product Type, Property, Design, End-User and Region.